Controlled release in sodium alendronate/halloysite/hydroxyapatite/gelatin nanocomposite scaffolds: A new insight into bone tissue engineering

The use of smart scaffolds with drug release capabilities is now widely recognized as a key approach in designing hard tissue substitutes. In this study, alendronate sodium (AL) was bound to halloysite nanotube (HNT) sheets through ionic and π-π interactions. Hydroxyapatite (HA) powder was synthesized using the co-precipitation method, and the drug/carrier complex was subsequently incorporated into a hydroxyapatite/gelatin (GEL) matrix. Composite scaffolds of GEL/HA/HNT/AL were then created using a freeze-drying technique. Different concentrations of HNT (0.5 %, 1 %, and 2 %) were tested to determine the optimal formulation. The scaffolds were subjected to extensive physical, chemical, and mechanical evaluations using scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), compressive stress tests, and measurements of density and porosity. The release profile of alendronate sodium, scaffold swelling behavior in water, bioactivity, and in vitro performance were thoroughly assessed. Cell viability was tested using the MTT assay, while alkaline phosphatase (ALP) activity and cell adhesion studies were performed to evaluate osteogenic potential. The results revealed that the GEL/HA/1 % HNT/AL nanocomposite scaffold exhibited excellent properties, including efficient drug release, optimal swelling rates, and enhanced bioactivity. The MTT assay confirmed high cell viability, and both ALP activity and cell adhesion studies indicated strong potential for bone cell differentiation and repair. Thus, the GEL/HA/1 % HNT/AL nanocomposite scaffold is a highly promising platform for bone tissue engineering.